Altoida AG

As a predictive digital biomarker company, Altoida, Inc. has developed technology using smart device sensors to measure cognition, function and motor skills. The innovation is based on three major pillars: (1) Active Digital Biomarkers, (2) Artificial Intelligence and (3) Augmented Reality. Altoida's Digital Neuro Signatures (DNS) is an FDA-cleared class II medical device, that collects data from the electronics sensors in the users device to analyze 748 proprietary digital biomarkers and provide an objective measurement of brain function across 11 neurocognitive domains and subdomains, (backed by DSM-5 criteria) and a novel Digital Neuro Signature score.